Global report - October 5, 2016
EU-US collaboration to combat rare diseases
The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) have set up a new ‘cluster’ on rare diseases to share experiences and best practices on each other’s regulatory approach to the development of medicines for these diseases. While rare diseases are estimated to affect 30 million people in the European […]
Uncategorized - April 21, 2015
Finland Ready for mHealth
Finland offers the third best market prerequisites for the mHealth business among the EU countries, according to a survey conducted by research2guidance in collaboration with HIMSS Europe. More than 4,000 app developers, healthcare professionals and mHealth practitioners contributed to the “The EU Countries’ mHealth App Market Ranking” survey. mHealth stands for mobile Health, which refers […]
Pharma Business - December 9, 2013
AstraZeneca receives EU approval for vaccine
AstraZeneca has announced that the European Commission (EC) has granted marketing authorisation to its nasally administered four-strain flu vaccine Fluenz Tetra. The company said in a press release today that the approval makes the vaccine, aimed for the prevention of influenza in children and adolescents from 24 months to 18 years of age, the first […]
Uncategorized - October 30, 2013
EU funded effort to develop new stroke therapies
The COUNTERSTROKE consortium led by researchers at Karolinska Institutet today initiates a six million Euro EU funded collaboration to develop novel therapeutics to treat stroke. Stroke and other conditions related to a decreased oxygen supply to the brain are the third most common cause of death in Europe. One out of three stroke incidents lead […]
